Cartesian Therapeutics (RNAC)

• Market cap: $268M
• 1 day: 1.03%
• 5 days: 12.17%
• 1 month: -11.94%
• 3 months: 8.46%
• 6 months: 36.15%
• Year to date: 30.92%
• 1 year: -16.03%
• 5 years: -92.36%
• 10 years: -97.36%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Employees: 75